Harvard Comprehensive Updates in Nephrology 2025
Include: 94 videos 56 pdfs , size: 197 GB
Comprehensive Nephrology Continuing Education Event
Updates, advances and practical information you can use now to screen, diagnose and manage patients with kidney disease
With more than 50 interactive lectures and case-based sessions, this program provides a comprehensive update of the most important changes now impacting Nephrology with guidance on how to incorporate these changes into your clinical practice to optimize patient care and improve outcomes.
Many practicing nephrologists and physicians find it difficult to keep up with the rapid scientific and technological advances in renal care because medicine is changing at a faster pace than ever before. This live-streaming and fast-paced educational offering is taught by world-renowned experts and Harvard Medical School’s leading clinical faculty. The most important updates and advances in the diagnosis and treatment of kidney diseases will be taught, including practical information that you can use now to provide exceptional patient care.
We will address pathophysiologic and clinical issues in the major areas of nephrology, including:
- Glomerular disease
- Acute renal failure
- Kidney transplantation
- Xenotransplantion
- Immunosuppressive management
- Hypertension
- Pregnancy and renal disease
- Onco-nephrology
- Acid-base and fluid and electrolyte disorders
- Potassium balance
- Climate change and kidney disease
- Primary hyperaldosteronism
- Bone mineral disorders
- Lupus nephritis
- Diuretic resistance
- Dialysis
- Kidney stones
- Polycystic kidney disease
- Genetic renal diseases
- Cardiorenal and hepatorenal syndrome
Presenters will also discuss diagnostic testing, well-recognized medical complications, evidence-based treatment plans and provide specific management strategies and recommendations to optimize care.
Designed by and for clinicians, the curriculum focuses on state-of-the-art approaches to the challenges we face and the best ways to apply these approaches to our practice to provide exceptional patient care
Highlights of this program include:
- New Medications: Practical applications of the latest treatments for diabetes mellitus, proteinuria and obesity in the context of CKD.
- Hypertension Management: The latest strategies for controlling hypertension, focusing on the role of aldosterone excess.
- Renal Diseases: Advanced insights into the pathogenesis, diagnosis and management of IgA nephropathy, membranous nephropathy, minimal change disease and FSGS.
- Genetic Testing: Up-to-date guidance on genetic testing and its importance in the CKD clinic.
- Kidney Transplantation: A comprehensive overview of kidney transplantation, addressing infections, malignancies and common complications.
- Immunosuppressive Therapies: Crucial updates on immunosuppressive treatments for kidney transplant recipients, including novel therapies.
- Dialysis Management: Best practices for managing dialysis access and peritoneal dialysis, including handling complications.
- Electrolyte and Acid-Base Disorders: State-of-the-art sessions on the physiology of electrolyte and acid-base disorders.
- Onco-Nephrology: In-depth exploration of this emerging field and its clinical implications.
This is an excellent opportunity to learn the latest “best practices” and enhance your clinical skills. Both new and returning attendees will benefit from the comprehensive curriculum.
WHO SHOULD ATTEND?
- Nephrologists
- Internists
- Family-medicine physicians
- PAs
- Nurse practitioners
- Healthcare providers interested in refreshing their knowledge
Topics:
25-732938-Schedule.pdf
March 16 Afternoon.ts
March 16 Detours in Hypertension- Evaluation and Management- Bradley M. Denker, MD.pdf
March 16 Detours in Hypertension- Evaluation and Management- Bradley M. Denker, MD.ts
March 16 IgA Nephropathy and H-S Purpura- Individualizing Therapy Ronald J. Falk, MD.pdf
March 16 IgA Nephropathy and H-S Purpura- Individualizing Therapy Ronald J. Falk, MD.ts
March 16 Membranous Glomerulopathy and Focal Segmental Glomerulosclerosis, Minimal Change Disease Ronald J. Falk, MD.pdf
March 16 Membranous Glomerulopathy and Focal Segmental Glomerulosclerosis, Minimal Change Disease Ronald J. Falk, MD.ts
March 16 Morning.ts
March 16 Optimizing Renal Support in Acute Kidney Injury- Case-Based Discussions Paul M. Palevsky, MD References.pdf
March 16 Optimizing Renal Support in Acute Kidney Injury- Case-Based Discussions Paul M. Palevsky, MD.pdf
March 16 Optimizing Renal Support in Acute Kidney Injury- Case-Based Discussions Paul M. Palevsky, MD.ts
March 16 Prevention and Treatment of Acute Kidney Injury- A Comprehensive Primer- Paul M. Pavlevsky, MD References.pdf
March 16 Prevention and Treatment of Acute Kidney Injury- A Comprehensive Primer- Paul M. Pavlevsky, MD.pdf
March 16 Prevention and Treatment of Acute Kidney Injury- A Comprehensive Primer- Paul M. Pavlevsky, MD.ts
March 16 Prevention and Treatment of Common PD Complications An Interactive Session Adam M. Segal, MD, FASN.pdf
March 16 Prevention and Treatment of Common PD Complications An Interactive Session Adam M. Segal, MD, FASN.ts
March 16 Question-and-Answer Session Adam M. Segal, MD, FASN.ts
March 16 Question-and-Answer Session Bradley M. Denker, MD.ts
March 16 Question-and-Answer Session Paul M. Palevsky, MD.ts
March 16 Question-and-Answer Session Ronald J. Falk, MD S. Ananth Karumanchi, MD (1).ts
March 16 Question-and-Answer Session Ronald J. Falk, MD S. Ananth Karumanchi, MD (2).ts
March 16 Renal Disease and Pregnancy S. Ananth Karumanchi, MD.pdf
March 16 Renal Disease and Pregnancy S. Ananth Karumanchi, MD.ts
March 16 State-of-the-Art Approaches to Small-Vessel Vasculitis Ronald J. Falk, MD.pdf
March 16 State-of-the-Art Approaches to Small-Vessel Vasculitis Ronald J. Falk, MD.ts
March 17 Afternoon.ts
March 17 Case-Based Workshop- Acid-Base Clinical Cases Michael Emmett, MD.pdf
March 17 Case-Based Workshop- Acid-Base Clinical Cases Michael Emmett, MD.ts
March 17 Case-Based Workshop- Fluid and Electrolytes Richard H. Sterns, MD.pdf
March 17 Case-Based Workshop- Fluid and Electrolytes Richard H. Sterns, MD.ts
March 17 Challenges in Dialysis Access Amy R. Evenson, MD, MPH.pdf
March 17 Challenges in Dialysis Access Amy R. Evenson, MD, MPH.ts
March 17 Endocrine Hypertension- Primary Aldosteronism and Pheochromocytoma Anand Vaidya, MD, MMSc.pdf
March 17 Endocrine Hypertension- Primary Aldosteronism and Pheochromocytoma Anand Vaidya, MD, MMSc.ts
March 17 Morning.ts
March 17 Question-and-Answer Session Amy R. Evenson, MD, MPH.ts
March 17 Question-and-Answer Session Anand Vaidya, MD, MMSc.ts
March 17 Question-and-Answer Session Richard H. Sterns, MD.ts
March 17 Relation Between Salt and Water Richard H. Sterns, MD.pdf
March 17 Relation Between Salt and Water Richard H. Sterns, MD.ts
March 17 SELF-STUDY SESSION – Acid-Base- Elementary Issues Michael Emmett, MD.ts
March 17 The Anion Gap- An Enduring Concept for over 100 Years Michael Emmett, MD.pdf
March 17 The Anion Gap- An Enduring Concept for over 100 Years Michael Emmett, MD.ts
March 17 The Forgotten Compartment- Tales From the Tubulointerstitium Melanie P. Hoenig, MD.pdf
March 17 The Forgotten Compartment- Tales From the Tubulointerstitium Melanie P. Hoenig, MD.ts
March 17 The Management of the Incidentally Discovered Adrenal Mass Anand Vaidya, MD, MMSc.pdf
March 17 The Management of the Incidentally Discovered Adrenal Mass Anand Vaidya, MD, MMSc.ts
March 18 Advanced Kidney Disease in Vulnerable Patients- Prognosis and Treatment Decision Conversations- Robert A. Cohen, MD, MSc.pdf
March 18 Advanced Kidney Disease in Vulnerable Patients- Prognosis and Treatment Decision Conversations- Robert A. Cohen, MD, MSc.ts
March 18 Advances in Phosphate Homeostasis Management Jessica Kendrick, MD.pdf
March 18 Advances in Phosphate Homeostasis Management Jessica Kendrick, MD.ts
March 18 Afternoon.ts
March 18 APOL1-Associated Kidney Disease Martin Pollak, MD.pdf
March 18 APOL1-Associated Kidney Disease Martin Pollak, MD.ts
March 18 Comprehensive Genetic Analysis in Nephrology Ali Gharavi, MD.pdf
March 18 Comprehensive Genetic Analysis in Nephrology Ali Gharavi, MD.ts
March 18 Disorders of Potassium Balance- Something Old and Something New- Melanie P. Hoenig, MD.pdf
March 18 Disorders of Potassium Balance- Something Old and Something New- Melanie P. Hoenig, MD.ts
March 18 Hemodialysis Delivery- Complications and the Barriers to Adequate Dialysis- J. Kevin Tucker, MD.pdf
March 18 Hemodialysis Delivery- Complications and the Barriers to Adequate Dialysis- J. Kevin Tucker, MD.ts
March 18 Human Xenotransplantation- Daniel C. Brennan, MD, FACP References.pdf
March 18 Human Xenotransplantation- Daniel C. Brennan, MD, FACP.pdf
March 18 Human Xenotransplantation- Daniel C. Brennan, MD, FACP.ts
March 18 Immunosuppressive Management in Acute Infection and Malignancy in Kidney Transplantation- Daniel C. Brennan, MD, FACP References.pdf
March 18 Immunosuppressive Management in Acute Infection and Malignancy in Kidney Transplantation- Daniel C. Brennan, MD, FACP.pdf
March 18 Immunosuppressive Management in Acute Infection and Malignancy in Kidney Transplantation- Daniel C. Brennan, MD, FACP.ts
March 18 Morning.ts
March 18 Onco-Nephrology- A Primer for the Nephrologist- Kavita Mistry, MD, PhD.pdf
March 18 Onco-Nephrology- A Primer for the Nephrologist- Kavita Mistry, MD, PhD.ts
March 18 Question-and-Answer Session Bradley M. Denker, MD.ts
March 18 Question-and-Answer Session Daniel C. Brennan, MD, FACP.ts
March 18 Question-and-Answer Session J. Kevin Tucker, MD.ts
March 18 Question-and-Answer Session Jessica Kendrick, MD.ts
March 18 Question-and-Answer Session Kavita Mistry, MD, PhD.ts
March 18 Question-and-Answer Session Martin Pollak, MD Ali Gharavi, MD.ts
March 18 Question-and-Answer Session Melanie P. Hoenig, MD.ts
March 18 Updates on the Management of Chronic Kidney Disease- Bradley M. Denker, MD.pdf
March 18 Updates on the Management of Chronic Kidney Disease- Bradley M. Denker, MD.ts
March 19 A Comprehensive Overview of Hypertension Management in 2025 Bradley M. Denker, MD.pdf
March 19 A Comprehensive Overview of Hypertension Management in 2025 Bradley M. Denker, MD.ts
March 19 Afternoon.ts
March 19 BURTON D. ROSE KEYNOTE PRESENTATION- Noninfectious Complications of Kidney Transplantation Martha Pavlakis, MD.pdf
March 19 BURTON D. ROSE KEYNOTE PRESENTATION- Noninfectious Complications of Kidney Transplantation Martha Pavlakis, MD.ts
March 19 Case-Based Workshop- Problems in Dialysis John Danziger, MD, MPhil.pdf
March 19 Case-Based Workshop- Problems in Dialysis John Danziger, MD, MPhil.ts
March 19 Finding the Right Pathway for a Patient With the Declining Allograft- Martha Pavlakis, MD.pdf
March 19 Finding the Right Pathway for a Patient With the Declining Allograft- Martha Pavlakis, MD.ts
March 19 Maintenance of Immunosuppression in Kidney Transplantation Martha Pavlakis, MD.pdf
March 19 Maintenance of Immunosuppression in Kidney Transplantation Martha Pavlakis, MD.ts
March 19 Morning.ts
March 19 Novel Dialysis Modalities for Chronic Patients John Danziger, MD, MPhil.pdf
March 19 Novel Dialysis Modalities for Chronic Patients John Danziger, MD, MPhil.ts
March 19 Pathology and Mechanisms of Glomerular Diseases Astrid Weins, PhD, MD.pdf
March 19 Pathology and Mechanisms of Glomerular Diseases Astrid Weins, PhD, MD.ts
March 19 Question-and-Answer Session Astrid Weins, PhD, MD.ts
March 19 Question-and-Answer Session Bradley M. Denker, MD.ts
March 19 Question-and-Answer Session David J. Friedman, MD.ts
March 19 Question-and-Answer Session John Danziger, MD, MPhil.ts
March 19 Question-and-Answer Session Mark L. Zeidel, MD.ts
March 19 Question-and-Answer Session Martha Pavlakis, MD.ts
March 19 SPECIAL LECTURE- Heat-Induced CKD David J. Friedman, MD.pdf
March 19 SPECIAL LECTURE- Heat-Induced CKD David J. Friedman, MD.ts
March 19 What’s New. Controversies in Salt and Water Mark L. Zeidel, MD.pdf
March 19 What’s New. Controversies in Salt and Water Mark L. Zeidel, MD.ts
March 20 Afternoon.ts
March 20 Anemia in CKD and ESKD- What We Know and What We Are Learning Jeffrey H. William, MD.pdf
March 20 Anemia in CKD and ESKD- What We Know and What We Are Learning Jeffrey H. William, MD.ts
March 20 Case-Based Workshop- Challenging Cases in Glomerular Disease Helmut G. Rennke, MD.pdf
March 20 Case-Based Workshop- Challenging Cases in Glomerular Disease Helmut G. Rennke, MD.ts
March 20 Case-Based Workshop- Challenging Glomerular Biopsy Cases Gerald B. Appel, MD.pdf
March 20 Case-Based Workshop- Challenging Glomerular Biopsy Cases Gerald B. Appel, MD.ts
March 20 Challenging Clinical Questions- Case-Based Session Robert S. Brown, MD.pdf
March 20 Challenging Clinical Questions- Case-Based Session Robert S. Brown, MD.ts
March 20 Management of Hypertension in Nephropathy and Diabetes- An Update Sylvia E. Rosas, MD, MSCE.pdf
March 20 Management of Hypertension in Nephropathy and Diabetes- An Update Sylvia E. Rosas, MD, MSCE.ts
March 20 Management of Nondiabetic Chronic Kidney Disease Leslie Inker, MD, MS.pdf
March 20 Management of Nondiabetic Chronic Kidney Disease Leslie Inker, MD, MS.ts
March 20 Morning.ts
March 20 Question-and-Answer Session Gerald B. Appel, MD.ts
March 20 Question-and-Answer Session Helmut G. Rennke, MD.ts
March 20 Question-and-Answer Session Jeffrey H. William, MD.ts
March 20 Question-and-Answer Session Sylvia E. Rosas, MD, MSCE.ts
March 20 Renal Aspects of Dysproteinemias Gerald B. Appel, MD.pdf
March 20 Renal Aspects of Dysproteinemias Gerald B. Appel, MD.ts
March 20 Treating Lupus Nephritis in 2025 Gerald B. Appel, MD.pdf
March 20 Treating Lupus Nephritis in 2025 Gerald B. Appel, MD.ts
March 21 A Comprehensive Look at Renal Stones- Strategies and Treatment Options Gary C. Curhan, MD, ScD.pdf
March 21 A Comprehensive Look at Renal Stones- Strategies and Treatment Options Gary C. Curhan, MD, ScD.ts
March 21 Afternoon.ts
March 21 Challenging Cases in Renal Disease- An Interactive Session.pdf
March 21 Challenging Cases in Renal Disease- An Interactive Session.ts
March 21 Diagnosis and Management of Thrombotic Microangiopathies Jai Radhakrishnan, MD, MS.pdf
March 21 Diagnosis and Management of Thrombotic Microangiopathies Jai Radhakrishnan, MD, MS.ts
March 21 Diuretic Strategies in CHF, NS, Cirrhosis and CKD Jai Radhakrishnan, MD, MS.pdf
March 21 Diuretic Strategies in CHF, NS, Cirrhosis and CKD Jai Radhakrishnan, MD, MS.ts
March 21 Management of Polycystic Kidney Disease Peter G. Czarnecki, MD.pdf
March 21 Management of Polycystic Kidney Disease Peter G. Czarnecki, MD.ts
March 21 Morning.ts
March 21 Question-and-Answer Session & Closing Remarks strong Stewart H. Lecker, MD, PhD.ts
March 21 Question-and-Answer Session Gary C. Curhan, MD, ScD.ts
March 21 Question-and-Answer Session Jai Radhakrishnan, MD, MS 1.ts
March 21 Question-and-Answer Session Jai Radhakrishnan, MD, MS 2.ts
March 21 Question-and-Answer Session Peter G. Czarnecki, MD.ts
March 21 Question-and-Answer Session Peter Steinberg, MD.ts
March 21 Selected Management Issues in Nephrotic Syndrome Jai Radhakrishnan, MD, MS.pdf
March 21 Selected Management Issues in Nephrotic Syndrome Jai Radhakrishnan, MD, MS.ts
March 21 What Urologists Wish Nephrologists Would Know Peter Steinberg, MD.pdf
March 21 What Urologists Wish Nephrologists Would Know Peter Steinberg, MD.ts
Neph-Compiled-QA.pdf
Related products
All Products
Perface Academy Rhinoplasty Encyclopedia – SV – Mastering The Art